Our Research Projects
Our lab is committed to advancing knowledge of pregnancy and birth outcomes
through a variety of genomic and multi-omics approaches. Below is an overview
of our key research directions.
1. Integrating Genomic Studies of Gestational Duration and Birth Weight
We investigate two closely linked birth outcomes—gestational duration and
birth weight—by analyzing both maternal and fetal genetic contributions.
By leveraging large cohorts and novel statistical methods, we aim to uncover
how these outcomes are genetically interconnected and how they relate to
longer-term health, ultimately providing insights for preventing adverse
pregnancy outcomes.
2. Genomics of Pregnancy Outcomes and Multi-Omics in LMICs
In collaboration with the Multi-Omics for Mothers and Infants (MOMI) Consortium,
we employ low-pass whole-genome sequencing and other omics technologies to
study pregnancy phenotypes in diverse populations across low- and middle-income
countries. By comparing genetic and environmental factors in these understudied
populations, we aim to identify genetic variants that influence gestational
duration, fetal growth, and maternal health—ultimately reducing disparities
in global birth outcomes.
3. Epigenomics of Pregnancy Outcomes and Prediction Using Epigenomic Marks
Recognizing the critical role of gene–environment interactions during pregnancy,
we examine DNA methylation patterns in both mothers and newborns. Our goals are
to identify epigenetic changes linked to adverse outcomes, chart how these
changes evolve throughout pregnancy, and explore the potential for epigenomic
biomarkers to predict complications. This work integrates seamlessly with our
multi-omics approach to uncover the mechanisms driving pregnancy health.
4. Functional Studies of Genes and Genetic Variants Associated with Pregnancy Outcomes
Beyond identifying genetic loci through large-scale genomic analyses, we
conduct in-depth experiments to validate and characterize these variants
in cell-based systems, animal models, and multi-omics assays. This often
involves assessing gene expression, leveraging CRISPR-based editing, and
examining downstream molecular pathways in relevant tissues. By pinpointing
how specific genes and variants influence conditions such as preterm birth
or restricted fetal growth, we aim to translate genetic discoveries into
actionable strategies that improve maternal and neonatal health.